Éric Eeckhout

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory

Morton J. Kern, Amir Lerman, Jan-Willen Bech et al. · Circulation · 2006 · 490 citations · Full text

Heart Failure, Cardiac Catheterization Laboratory, Catheterization Lab +18

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

Michael Haude, Hüseyin İnce, Alexandre Abizaid et al. · The Lancet · 2015 · 347 citations

Tissue Engineering, Percutaneous Coronary Intervention, Cardiovascular Disease +9

Outcome of Elderly Patients With Chronic Symptomatic Coronary Artery Disease With an Invasive vs Optimized Medical Treatment Strategy

Matthias Pfisterer, Peter Buser, Stefan Osswald et al. · JAMA · 2003 · 253 citations · Full text

Does Stenosis Severity of Native Vessels Influence Bypass Graft Patency? A Prospective Fractional Flow Reserve–Guided Study

Cornelis J. Botman, Jacques P.A.M. Schönberger, Sjaak Koolen et al. · The Annals of Thoracic Surgery · 2007 · 236 citations · Full text

Does Stenosis Severity, Endovascular Technique, Cardiovascular Disease +5